|
| 自噬与非小细胞肺癌耐药 |
| Autophagy and drug resistance in non-small cell lung cancer |
| 投稿时间：2022-08-04 修订日期：2023-09-20 |
| DOI： |
| 中文关键词: 自噬；非小细胞肺癌；耐药 |
| 英文关键词: autophagy；non-small cell lung cancer；drug resistance |
| 基金项目:国家自然科学基金 |
| 作者 | 单位 | 邮编 | | 吕莹 | 济宁医学院 | 272011 | | 相龙全* | 济宁市第一人民医院 | 272011 |
|
| 摘要点击次数: 103 |
| 全文下载次数: 0 |
| 中文摘要: |
| 耐药是非小细胞肺癌临床治疗中面临的一个巨大难题，与肿瘤复发和转移密切相关，且降低了药物治疗效果并增加了患者的死亡率。自噬是一个进化保守的分子生物过程，通过与溶酶体结合降解细胞器和蛋白质以维持细胞稳态。考虑到自噬与非小细胞肺癌发展过程及耐药密切相关，并且靶向调节非小细胞肺癌的自噬相关基因可影响药物敏感性，改变非小细胞肺癌的治疗效果。本文就自噬与非小细胞肺癌耐药进行综述。 |
| 英文摘要: |
| Drug resistance is a huge challenge in the clinical treatment of non-small cell lung cancer, which is closely related to tumor recurrence and metastasis, seriously reduces the efficacy of drug treatment and increases patient mortality. Autophagy is an evolutionarily conserved metabolic process in eukaryotes. It maintains cell homeostasis by regulating organelles and protein degradation. In view of the fact that autophagy is tightly correlated with the development process and drug resistance of non-small cell lung cancer, and targeting autophagy-related genes of non-small cell lung cancer can affect drug sensitivity and alter the therapeutic effect of non-small cell lung culture. This article provides a review of autophagy and drug resistance in non-small cell lung cancer. |
|
View Fulltext
查看/发表评论 下载PDF阅读器 |
